Platelet Transfusion

• 

  Subject Areas on Research

  • A comparison of adverse reaction rates for PAS C versus plasma platelet units. 
  • Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy. 
  • Bacterial contamination of platelets for transfusion: strategies for prevention. 
  • Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee. 
  • Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. 
  • Defining Usage and Clinical Outcomes Following Perioperative Fresh Frozen Plasma and Platelet Administration in Spine Surgery Patients. 
  • Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? 
  • Dose of prophylactic platelet transfusions and prevention of hemorrhage. 
  • Editorial: platelet transfusions in cirrhosis-do the risks outweigh the unclear benefits? 
  • Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. 
  • Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. 
  • Encouraging single-unit transfusions: a superior patient blood management strategy? 
  • Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. 
  • Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. 
  • Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States. 
  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. 
  • High-dose intravenous immunoglobulin for severe platelet alloimmunization. 
  • Human platelets activate porcine endothelial cells through a CD154-dependent pathway. 
  • Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. 
  • Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. 
  • International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis. 
  • Intracerebral hemorrhage after pipeline embolization: Management of antiplatelet agents and the case for point-of-care testing--case reports and review of literature. 
  • Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth. 
  • Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. 
  • Marrow transplantation for thalassaemia. 
  • Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease. 
  • Neonatal alloimmune thrombocytopenic purpura. 
  • Perioperative Management of the Gynecologic Patient on Long-term Anticoagulation. 
  • Perioperative Removal of Autologous Platelets. 
  • Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. 
  • Platelet Transfusion Practices in Critically Ill Children. 
  • Platelet transfusion increases risk for acute respiratory distress syndrome in non-massively transfused blunt trauma patients. 
  • Platelet transfusion reactions: febrile nonhemolytic reaction or bacterial contamination? Diagnosis, detection, and current preventive modalities. 
  • Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. 
  • Platelet transfusions: utilization and associated costs in a tertiary care hospital. 
  • Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. 
  • Platelet-mediated thrombolysis in patients with δ-storage pool deficiency: a thrombelastographic analysis. 
  • Pregnancy in patients with thrombocytopenia and absent radii (TAR) syndrome. 
  • Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. 
  • Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy. 
  • Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors? 
  • Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. 
  • Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery. 
  • Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods. 
  • Secondary failure of platelet recovery after hematopoietic stem cell transplantation. 
  • Septic risk increases with apheresis platelet storage time. 
  • Storage age of transfused platelets and outcomes after cardiac surgery. 
  • Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review. 
  • Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. 
  • Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. 
  • Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature. 
  • Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors. 
  • Update on multi-center clinical trials in the United States. 
  • Variation in use of blood transfusion in coronary artery bypass graft surgery. 
  • Vincristine therapy for severe platelet alloimmunization. 
  • What Is the PROPPR Transfusion Strategy in Trauma Resuscitation? 
  • What is the evidence for platelet transfusion in perioperative settings? 
• 

  Keywords of People

  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery